News Conference News TCT 2012 Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology October 24, 2012
Presentation TCT 2012 TCT-45. Long Term Safety and Effectiveness of XIENCE V® Everolimus Eluting Coronary Stent System in Real-world Population: Three-Year Clinical Outcomes from the XIENCE V® USA Study Presenter: James Hermiller Jr October 23, 2012
News Conference News TCT 2012 Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year October 22, 2012
Presentation TCT 2012 Dedicated Bifurcation Stents: Xience SBA Program Update Presenter: David Rizik October 22, 2012
News Conference News TCT 2012 COURAGE, FAME: Revascularization More Effective Than OMT October 22, 2012
News Daily News Las Fracturas del Stent Persisten en los Dispositivos de Nueva Generación Jason Kahn October 02, 2012
News Daily News Un Registro Coreano Confirma la Superioridad de los Stents liberadores de Everolimus sobre los de Zotarolimus September 19, 2012
News Daily News Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents September 19, 2012
News Daily News SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis Yael L. Maxwell September 07, 2012
News Daily News SORT OUT IV: El Xience Aguanta el Tirón del Cypher en la Prevención de la Trombosis del Stent Yael L. Maxwell September 07, 2012
News Conference News ESC 2012 OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon Caitlin E. Cox August 29, 2012
News Industry News Abbott Announces CE Mark and European Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent August 20, 2012
News Daily News Meta-analysis: DES Acceptable but Not Trouble-Free for Left Main Disease Caitlin E. Cox August 16, 2012
News Daily News Se Publica el RESET: Eficacia y Seguridad Parecidas con SLE y SLS al cabo de 1 Año L.A. McKeown July 30, 2012
News Daily News RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year L.A. McKeown July 30, 2012